Skip to main content
. 2022 Feb 11;9:758464. doi: 10.3389/fmed.2022.758464

Figure 1.

Figure 1

Patient enrollment and testing workflow. Flowchart showing the patient enrolment, diagnosis, sample availability, type of testing conducted, and mutation findings. Gray-filled boxes indicate testing results from plasma next-generation sequencing (NGS) and red-outlined boxes are all clinically actionable findings made in this study for non-small cell lung carcinoma (NSCLC) cases.